Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Human Sensory LTP Predicts Memory Performance and Is Modulated by the BDNF Val66Met Polymorphism.

Spriggs MJ, Thompson CS, Moreau D, McNair NA, Wu CC, Lamb YN, McKay NS, King ROC, Antia U, Shelling AN, Hamm JP, Teyler TJ, Russell BR, Waldie KE, Kirk IJ.

Front Hum Neurosci. 2019 Feb 15;13:22. doi: 10.3389/fnhum.2019.00022. eCollection 2019.

2.

Integrating Space, Time, and Orientation in Spiking Neural Networks: A Case Study on Multimodal Brain Data Modeling.

Sengupta N, McNabb CB, Kasabov N, Russell BR.

IEEE Trans Neural Netw Learn Syst. 2018 Nov;29(11):5249-5263. doi: 10.1109/TNNLS.2018.2796023. Epub 2018 Feb 13.

PMID:
29994642
3.

Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia.

McNabb CB, Tait RJ, McIlwain ME, Anderson VM, Suckling J, Kydd RR, Russell BR.

Schizophr Res. 2018 May;195:160-167. doi: 10.1016/j.schres.2017.10.015. Epub 2017 Oct 16.

PMID:
29042073
4.

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU.

Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503. Epub 2016 Dec 6. Review.

5.

Fluoxetine Does Not Enhance Visual Perceptual Learning and Triazolam Specifically Impairs Learning Transfer.

Lagas AK, Black JM, Byblow WD, Fleming MK, Goodman LK, Kydd RR, Russell BR, Stinear CM, Thompson B.

Front Hum Neurosci. 2016 Oct 19;10:532. eCollection 2016.

6.

Varenicline improves motor and cognitive symptoms in early Huntington's disease.

McGregor AL, Dysart J, Tingle MD, Russell BR, Kydd RR, Finucane G.

Neuropsychiatr Dis Treat. 2016 Sep 19;12:2381-2386. eCollection 2016.

7.

Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.

Lee H, Wang GY, Curley LE, Kydd RR, Kirk IJ, Russell BR.

Psychopharmacology (Berl). 2016 Aug;233(15-16):2869-77. doi: 10.1007/s00213-016-4335-5. Epub 2016 Jun 11.

PMID:
27289365
8.

Using fMRI to compare the effects of benzylpiperazine with dexamphetamine - Their differences during the Stroop paradigm.

Curley LE, Kydd RR, Kirk IJ, Russell BR.

J Integr Neurosci. 2016 Mar;15(1):109-22. doi: 10.1142/S0219635216500084. Epub 2016 Feb 25.

PMID:
26912213
9.

Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.

Lee H, Wang GY, Curley LE, Sollers JJ, Kydd RR, Kirk IJ, Russell BR.

Psychopharmacology (Berl). 2016 Mar;233(5):863-71. doi: 10.1007/s00213-015-4165-x. Epub 2015 Dec 3.

PMID:
26630992
10.

Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?

Anderson VM, McIlwain ME, Kydd RR, Russell BR.

Psychiatry Res. 2015 Dec 30;230(3):811-8. doi: 10.1016/j.psychres.2015.10.036. Epub 2015 Oct 31.

PMID:
26564550
11.

Comparative quantification of dietary supplemented neural creatine concentrations with (1)H-MRS peak fitting and basis spectrum methods.

Turner CE, Russell BR, Gant N.

Magn Reson Imaging. 2015 Nov;33(9):1163-1167. doi: 10.1016/j.mri.2015.06.018. Epub 2015 Jun 25.

PMID:
26117698
12.

Auditory event-related potentials in methadone substituted opiate users.

Wang GY, Kydd R, Russell BR.

J Psychopharmacol. 2015 Sep;29(9):983-95. doi: 10.1177/0269881115587929. Epub 2015 Jun 2.

PMID:
26038111
13.

Quantitative EEG and Low-Resolution Electromagnetic Tomography (LORETA) Imaging of Patients Undergoing Methadone Treatment for Opiate Addiction.

Wang GY, Kydd RR, Russell BR.

Clin EEG Neurosci. 2016 Jul;47(3):180-7. doi: 10.1177/1550059415586705. Epub 2015 May 22.

PMID:
26002855
14.

Resting EEG and ERPs findings in methadone-substituted opiate users: a review.

Wang GY, Kydd R, Russell BR.

Acta Neurol Belg. 2015 Dec;115(4):539-46. doi: 10.1007/s13760-015-0476-2. Epub 2015 Apr 19. Review.

PMID:
25894352
15.

Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.

Curley LE, Kydd RR, Robertson MC, Pillai A, McNair N, Lee H, Kirk IJ, Russell BR.

Psychopharmacology (Berl). 2015 Aug;232(16):2969-80. doi: 10.1007/s00213-015-3933-y. Epub 2015 Apr 19.

PMID:
25893641
16.

Extensive gray matter volume reduction in treatment-resistant schizophrenia.

Anderson VM, Goldstein ME, Kydd RR, Russell BR.

Int J Neuropsychopharmacol. 2015 Feb 25;18(7):pyv016. doi: 10.1093/ijnp/pyv016.

17.

Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers.

Lin JC, Jan RK, Kydd RR, Russell BR.

Drug Alcohol Depend. 2015 Apr 1;149:122-7. doi: 10.1016/j.drugalcdep.2015.01.026. Epub 2015 Jan 31.

PMID:
25700612
18.

Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.

Goldstein ME, Anderson VM, Pillai A, Kydd RR, Russell BR.

Int J Neuropsychopharmacol. 2015 Jan 20;18(6). pii: pyu117. doi: 10.1093/ijnp/pyu117.

19.

Changes in resting EEG following methadone treatment in opiate addicts.

Wang GY, Kydd R, Wouldes TA, Jensen M, Russell BR.

Clin Neurophysiol. 2015 May;126(5):943-50. doi: 10.1016/j.clinph.2014.08.021. Epub 2014 Sep 19.

PMID:
25301768
20.

Neuropsychological performance of methadone-maintained opiate users.

Wang GY, Wouldes TA, Kydd R, Jensen M, Russell BR.

J Psychopharmacol. 2014 Aug;28(8):789-99. doi: 10.1177/0269881114538541. Epub 2014 Jun 11.

PMID:
24920133

Supplemental Content

Loading ...
Support Center